CONCERTO/CONSULTA/MAXIMO II
FDA premarket approval P010031/S123 · decided 2008-10-17
Approval details
- PMA number
- P010031
- Supplement
- S123
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONCERTO/CONSULTA/MAXIMO II
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2008-09-19
- Decision date
- 2008-10-17
- Days to decision
- 28 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- CHANGE THE LASER RIBBON BONDING MANUFACTURING PROCESS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.